Guarana nootropic supplementation for cognitive performance before and after maximal exercise

Consulting service
University

Reverse dose-response study evaluating guarana as a natural nootropic alternative to caffeine for enhancing cognitive function (executive function, memory, attention, decision making) before and after maximal exercise, with applications for shift workers, emergency responders, and the general population.

Overview

This research investigates guarana (Paullinia cupana) as a natural nootropic alternative to caffeine, targeting cognitive performance before and after maximal physical exertion. The study addresses the cognitive challenges faced by emergency service professionals and shift workers, whose disrupted sleep-wake cycles can impair decision making, safety, and well-being. While caffeine is a common coping strategy, it can worsen circadian rhythms and sleep quality. Guarana, an FDA-approved natural extract rich in bioactive compounds, offers a promising alternative with potentially equal or superior cognitive benefits at lower caffeine doses. The research has particular relevance for military personnel, armed police, and other professionals who must make critical decisions following intense physical activity.

Technical specifications

Study design:

  • Randomised, double-blind, placebo-controlled, crossover, reverse dose-response trial
  • Guarana dosages tested: 125, 67.5, and 33.75 mg.kg.bw-1, with the highest dose matched for caffeine content
  • Caffeine threshold (positive control): 5 mg.kg.bw-1
  • Supplements consumed as beverages 30 minutes before initial cognitive testing

Cognitive assessments:

  • Executive function
  • Memory
  • Attention
  • Reaction time (simple and choice reaction time tests)
  • Word recall and Bond–Lader mood scale

Physical protocol:

  • Maximal exercise test (cycling V̇O2max) to simulate emergency response demands
  • Cognitive testing performed before and immediately after exercise

Prior validation findings:

  • Guarana (125 mg.kg.bw-1) decreased choice reaction time pre-exercise compared to placebo (407 vs. 421 ms, P = 0.030)
  • Improved simple reaction time post-exercise versus placebo (306 vs. 323 ms, P = 0.003)
  • Enhanced alertness scores compared to placebo (63.3 vs. 57.4, P = 0.014)
Technology readiness level

The research team has completed a prior double-blind randomised crossover study with 25 participants demonstrating guarana's cognitive benefits. The proposed study will further validate these findings through a more comprehensive dose-response design. The team offers extensive expertise in nutrition supplement, exercise, and cognitive science research, with capabilities spanning resting and exercise paradigms on cognitive and physical health. The research seeks funding for the proposed study and aims to establish a long-term research partnership to explore additional nootropic supplements.


About University College London

University College London is a comprehensive public research university in central London, integrated with major NHS teaching hospitals for clinically embedded research and rapid translation. Co‑located labs, maker spaces, and pilot‑scale facilities span Bloomsbury and the expanding East London campus, offering flexible industry access and residency options. Corporate engagement teams structure sponsored research, secondees, and bespoke consortia to align capabilities with product roadmaps. Research is supported by competitive funding from UK Research and Innovation, the National Institute for Health and Care Research, the Wellcome Trust, and European programs. A dedicated technology transfer company manages IP, licensing, and spinouts, with pathways to seed investment and scale‑up partners.

Sign up to access the full partnering listing.
View the details of this partnering listing and connect directly with the teams behind promising technologies.
Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.